Scheme Iron Regulated Metastasis Suppressor, NDRG1 and its Potential as a Molecular Target. App.1086449: 2014 Priority Driven Collaborative Cancer Research Scheme (PDCCRS): Priority-driven The Council of the Targeting suppressive TGF-βR Collaborative Cancer Queensland and A2AR pathways in Cancer $50,000.00 27/11/2014 12 Herston 4028 Australia Institute of Medical natural killer (NK) cells: Research Research Enhancing the Scheme response against breast cancer progression. App.1082709: CA-G1415/44 2014 Priority Driven Priority-driven Collaborative Cancer The Council of the Collaborative Research Scheme (PDCCRS): Cancer Queensland Cancer Eph Receptor Tyrosine Kinases $66,573.00 27/11/2014 24 Herston 4028 Australia Institute of Medical Research as Targets for Therapy in Research Scheme Paediatric Medulloblastoma. App.1080218: CA-G1415/45 2014 Priority Driven Collaborative Cancer Priority-driven Research Scheme (PDCCRS): Collaborative Queensland Cancer Targeting neuropilin-1 to Cancer University of $63,870.00 27/11/2014 24 Kelvin Grove 4059 Australia inhibit prostate cancer Research Technology metastasis and therapy Scheme resistance. App.1088878: 2014 Priority Driven Collaborative Cancer Priority-driven Research Scheme (PDCCRS): Collaborative Cancer University of Phase III trial of Concurrent & Cancer $190,213.00 28/02/2015 36 University of Sydney 2006 Australia Sydney Adjuvant Temozolomide Research chemotherapy in non-1p/19q Scheme deleted anaplastic glioma. App.1078665: CA-G1415/39 Priority-driven 2014 Priority Driven Cancer Collaborative University of Collaborative Cancer $90,253 02/04/2015 36 University of Sydney 2006 Australia Cancer Sydney Research Scheme (PDCCRS): Research SCOT - Short Course
Scheme Iron Regulated Metastasis Suppressor, NDRG1 and its Potential as a Molecular Target. App.1086449: Cancer Australia Priority-driven Collaborative Cancer Research Scheme The Council of the Queensland Institute of Medical Research 2014 Priority Driven Collaborative Cancer Research Scheme (PDCCRS): Targeting suppressive TGF-βR and A2AR pathways in natural killer (NK) cells: Enhancing the response against breast cancer progression. App.1082709: CA-G1415/44 $50,000.00 27/11/2014 12 Herston 4028 Cancer Australia Priority-driven Collaborative Cancer Research Scheme The Council of the Queensland Institute of Medical Research 2014 Priority Driven Collaborative Cancer Research Scheme (PDCCRS): Eph Receptor Tyrosine Kinases as Targets for Therapy in Paediatric Medulloblastoma. App.1080218: CA-G1415/45 $66,573.00 27/11/2014 24 Herston 4028 Cancer Australia Priority-driven Collaborative Cancer Research Scheme Queensland University of Technology 2014 Priority Driven Collaborative Cancer Research Scheme (PDCCRS): Targeting neuropilin-1 to inhibit prostate cancer metastasis and therapy resistance. App.1088878: $63,870.00 27/11/2014 24 Kelvin Grove 4059 Cancer Australia Priority-driven Collaborative Cancer Research Scheme University of Sydney 2014 Priority Driven Collaborative Cancer Research Scheme (PDCCRS): Phase III trial of Concurrent & Adjuvant Temozolomide chemotherapy in non-1p/19q deleted anaplastic glioma. App.1078665: CA-G1415/39 $190,213.00 28/02/2015 36 University of Sydney 2006 Cancer Australia Priority-driven Collaborative Cancer Research University of Sydney 2014 Priority Driven Collaborative Cancer Research Scheme (PDCCRS): SCOT - Short Course $90,253 02/04/2015 36 University of Sydney 2006
grants_reporting_20170703_3.docx